The Complainant, Boehringer Ingelheim Pharma GmbH & Co. KG, is the German company which is known as the global research-driven pharmaceutical enterprise (production of human pharmaceuticals, animal health products and biopharmaceuticals). The roots of this pharmaceutical business go back to 1885, when it was founded by Albert Boehringer (1861-1939) in Ingelheim am Rhein. The Complainant owns multiple domain names consisting in the wording “BOEHRINGER INGELHEIM”, such as <boehringer-ingelheim.com> registered since September 1, 1995.<\/p>\n
The disputed domain name <boehrinqer-ingelhiems.com> was registered on December 7, 2023, and resolves to a parking page with commercial links. Besides, MX servers are configured which shows Respondent‘s intent to use this domain name in e-mail communication. The Respondent is „shelby company“ (Nelson Shelby) from New York. <\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "
The Complainant submits that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n
NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.<\/p>", "rights": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "
The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "
The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Darius Sauliūnas" ], "date_of_panel_decision": "2024-01-14 00:00:00", "informal_english_translation": "
The Complainant is the owner of a large portfolio of trademarks including the wording “BOEHRINGER INGELHEIM” in several countries, such as the international trademark BOEHRINGER-INGELHEIM (Reg. No. 221544), registered since July 2, 1959, and duly renewed.<\/p>", "decision_domains": { "boehrinqer-ingelhiems.com": "TRANSFERRED" }, "panelist": null, "panellists_text": null }